KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Sep 2025 value amounting to 0.52.

  • Aurinia Pharmaceuticals' Asset Utilization Ratio rose 25.64% to 0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52, marking a year-over-year increase of 25.64%. This contributed to the annual value of 0.43 for FY2024, which is 24.24% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.52 for Q3 2025, which was down 0.06% from 0.52 recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.52 for Q2 2025, and its period low was 0.10 during Q4 2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Asset Utilization Ratio had a median value of 0.40 in 2024 and averaged 0.39.
  • Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Asset Utilization Ratio was 23,677.77% (2021), while the steepest drop was 7.09% (2021).
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.10 in 2021, then surged by 176.82% to 0.28 in 2022, then increased by 13.86% to 0.32 in 2023, then surged by 34.34% to 0.43 in 2024, then grew by 25.64% to 0.52 in 2025.
  • Its Asset Utilization Ratio was 0.52 in Q3 2025, compared to 0.52 in Q2 2025 and 0.47 in Q1 2025.